FDA Determines Regulatory Review Period for MAESTRO RECHARGEABLE SYSTEM Patent Extension

Summary

The U.S. Food and Drug Administration (FDA) has officially announced its decision regarding the regulatory review period for the patent extension of the MAESTRO RECHARGEABLE SYSTEM, a medical device, following a submission to the U.S. Patent and Trademark Office (USPTO).